• A
• B
• C
• D
• E
• F
• G
• H
• I
• K
• L
• M
• N
• O
• P
• R
• S
• T
• U
• V
• Z

Pembrolizumab (Keytruda®) adjuvant treatment of stage IIB or IIC melanoma. HTA ID: 22042

Pembrolizumab (Keytruda®) for Adjuvant melanoma

Pembrolizumab (Keytruda®) for adjuvant treatment of RCC. HTA ID: 22026

Pembrolizumab (Keytruda®) for classical Hodgkin Lymphoma. HTA ID: 21013

Pembrolizumab (Keytruda®) for colorectal cancer. HTA ID: 21002

Pembrolizumab (Keytruda®) for head and neck squamous cell carcinoma. HTA ID: 19051

Pembrolizumab (Keytruda®) for metastatic triple negative breast cancer. HTA ID: 21059

Pembrolizumab (Keytruda®) for neoadjuvant/adjuvant treatment of triple negative breast cancer. HTA ID: 22027

Pembrolizumab (Keytruda®) for NSCLC (first line)

Pembrolizumab (Keytruda®) for NSCLC (second line)